Israel's Teva Pharm to start paying US opioid settlement in 2023, says CEO
The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.
The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. (photo credit: REUTERS/AMIR COHEN)Updated: 
